Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-γ activation

Immunology

Volumn 103, Issue 1, 2001, Pages 41-48

  Martín Orozco, Natalia ^a,c   Isibasi, Armando ^a   Ortiz Navarrete, Vianney ^b,d  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b Depto de Biomedicina Molecular   (Mexico)

^c JOSLIN DIABETES CENTER   (United States)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; BREFELDIN A; GAMMA INTERFERON; LEUPEPTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SERINE PROTEINASE;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; PROTEIN STABILITY; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTIGEN PRESENTATION; BREFELDIN A; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; ENDOSOMES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; PEPTIDES; PROTEIN SYNTHESIS INHIBITORS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM;

EID: 0035008236     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0019-2805.2001.01226.x     Document Type: Article

References (40)

1. Richter-Dahlfors A, Buchan AMJ, Finlay B. Murine Salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J Exp Med 1997; 186:569-80.
2. Kaufmann SH. Immunity to intracellular bacteria. Annu Rev Immunol 1993; 11:129-63.
3. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to Interferon-γ. Annu Rev Immunol 1997; 15:749-95.
4. + TCR-αβ cells and IFN-γ in bacterial clearance independent of intracellular location. J Immunol 1996; 156:3321-26.
5. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993; 361:359-62.
6. Rock KL. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 1996; 17:131-7.
7. Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995; 264:243-53.
8. Lehner PJ, Cresswell P. Processing and delivery of peptides presented by MHC class I molecules. Curr Opin Immunol 1996; 8:59-67.
9. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996; 5:103-14.
10. Wick MJ, Pfeifer JD. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation. Eur J Immunol 1996; 26:2790-99.
11. Bachman MF, Oxenius A, Pircher H, Hengartner H, Ashton-Richardt PA, Tonegawa S, Zinkernagel RM. TAP1-independent loading of class I molecules by exogenous viral proteins. Eur J Immunol 1995; 25:1739-43.
12. Harding CV, Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 1994; 153:4925-33.
13. Song R, Harding CV. Roles of proteasomes, transporter for antigen presentation (TAP) and Beta 2-Microglobulin in the processing of exogenous or particulate antigens via an alternate class I MHC processing pathway. J Immunol 1996; 156:4182-90.
14. Ljunggren HG, Stam NJ, Ohlen C et al. Empty MHC class I molecules come out in the cold. Nature 1990; 346:476-80.
15. Rock KL, Gamble S, Rothstein L, Gramm C, Benacerraf B. Dissociation of β2-Microgobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface. Cell 1991; 65:511-20.
16. Ortiz-Navarrete V, Hammerling GJ. Surface appearance and instability of empty H-2 class I molecules under physiological conditions. Proc Natl Acad Sci USA 1991; 88:3594-7.
17. Kärre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy. Nature 1986; 319:675-9.
18. Walker W, Demus A. Antibody-dependent cytolysis of chicken erythrocytes by an in vitro established line of mouse peritoneal macrophages. J Immunol 1975; 114:765-9.
19. Ralf P, Prichard J, Cohn M. Reticulum cell sarcoma: an effector cell in antibody-dependent cell mediated immunity. J Immunol 1975; 114:895-905.
20. Plaut M, Lichtenstein LM, Gillespie E, Henney C. Studies on the mechanism of lymphocyte-mediated cytolysis. J Immunol 1973; 111:389-94.
21. Ozato K, Sachs DH. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol 1981; 126:317-21.
22. Isibasi A, Ortiz-Navarrete V, Vargas M, Paniagua J, Gonzalez C, Moreno J, Kumte J. Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12, d, Vi. Infect Immun 1988; 56:2953-9.
23. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988; 54:777-85.
24. Buchemeier NA, Heffron F. Intracellular survival of wild type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages. Infect Immun 1989; 57:1-7.
25. Wunderlich J, Shearer G. Induction and measurements of cytotoxic T lymphocyte activity. In: Coligan JE, Kruisbeek AM, Margulies D, Shevach EM, Strober W, eds. Current Protocols in Immunology, 2nd edn. New York, NY: Greene Publishing Associates, Inc and John Wiley & Sons, Inc., 1992; 1:3.11.1.
26. Lippincott-Schwartz J, Yuan L, Tipper C, Amherdt M, Orci L, Klausner RD. Brefeldin A's effects on endosomes, lysosomes, and the TGN suggests a general mechanism for regulating organelle structure and membrane traffic. Cell 1991; 67:601-16.
27. Jondal M, Schirmbeck R, Reimann J. MHC class I-restricted CTL responses to exogenous antigens. Immunity 1996; 5:259-302.
28. Reis e Sousa C, Germain RN. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 1995; 182:841-51.
29. Brossart P, Bevan MJ. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 1997; 90:1594-99.
30. Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ). Curr Opin Immunol 1997; 9:17-23.
31. Alpuche ACM, Swanson JA, Loomis WP, Miller SI. Salmonella typhimurium activates virulence gene transcription within acidified macrophages phagosomes. Proc Natl Acad Sci USA 1992; 89:10079-83.
32. Zhang Q, Cox D, Tseng CC, Donaldson JG, Greenberg S. A requirement for ARF6 in Fcγ receptor-mediated phagocytosis in macrophages. J Biol Chem 1998; 273:19977-81.
33. Fruh K, Yang Y. Antigen presentation by MHC class I and its regulation by interferon γ. Curr Opin Immunol 1999; 11:76-81.
34. Ortiz-Navarrete V, Seeling A, Gernold M, Frentzel S, Kloetzel PM, Hammerling GJ. Subunit of "20S" proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 1991; 353:662-4.
35. Gaczynska M, Rock KL, Goldberg AL. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993; 365:264-7.
36. Kurts C, Heath WR, Carbone FR, Allison J, Miller JFAP, Kosaka H. Constitutive Class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996; 184:923-30.
37. Carbone FR, Kurts C, Bennet SRM, Miller JFAP, Heath WR. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today 1998; 19:368-75.
38. Platt N, Da Silva RP, Gordon S. Recognizing death: the phagocytosis of apoptotic cells. Trends Cell Biol 1998; 8:365-16.
39. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic bodies. J Exp Med 2000; 191:411-16.
40. Heath WR, Kurts C, Caminschi I, Carbone FR, Miller JF. CD30 prevents T-cell responses to non lymphoid tissues. Immunol Rev 1999; 169:23-9.